A. Chiavegato et al., EXPRESSION OF MYOSIN HEAVY-CHAIN ISOFORMS IN MAMMARY EPITHELIAL-CELLSAND IN MYOFIBROBLASTS FROM DIFFERENT FIBROTIC SETTINGS DURING NEOPLASIA, Virchows Archiv, 426(1), 1995, pp. 77-86
The expression of smooth muscle (SM) and non-muscle (NM) myosin heavy
chain (MyHC) isoforms has been studied in fibroblastic cells of differ
ent fibrotic lesions (hypertrophic scars, Dupuytren's nodules and stro
mal reaction to mammary carcinoma) and in epithelial cells of non-neop
lastic and neoplastic mammary glands, using anti-myosin antibodies in
immunofluorescence and Western blotting. Two antibodies were specific
for SM-MyHC isoforms (SMI and SM2) and three antibodies were directed
against different sequences of NM-MyHC isoforms. Myofibroblasts contai
ning SM-MyHC were present in a variable number of cases of the differe
nt lesions: 1 of 11 hypertrophic scars, 3 of 9 Dupuytren's nodules and
20 of 25 breast cancers. The distribution of NM-MyHC sequences recogn
ized by our antibodies was heterogeneous in fibroblasts from normal de
rmis and mammary stroma, but became homogeneous in myofibroblasts from
all the pathological conditions examined. Moreover, the expression of
these MyHC sequences differed in normal mammary epithelium when compa
red with invasive carcinoma. These results show that cellular modulati
on from fibroblast to myofibroblast may be accompanied by the appearan
ce of SM-MyHC and is characterized by a uniform expression of MyHC of
NM type, and that tumour progression in mammary epithelial cells may b
e paralleled by the disappearance of a specific NM-MyHC sequence. This
suggests that MyHC modulation participates in the process of fibrosis
as well as in the process of malignant epithelial transformation.